Management of Hepatitis B Virus and Hepatitis C Virus Infections in Patients with Cancer Receiving Immune Checkpoint Inhibitors
ABSTRACT: Background: Patients with cancer with hepatitis B virus (HBV) or hepatitis C virus (HCV) infection are excluded from manycancer clinical trials of immune checkpoint inhibitors (ICIs). Therefore, data are limited regarding the management of HBV and HCV infectionsin patients with cancer trea...
Збережено в:
| Автори: | , , |
|---|---|
| Формат: | Artigo |
| Мова: | Inglês |
| Опубліковано: |
Innovative Healthcare Institute
2024-05-01
|
| Серія: | Journal of Immunotherapy and Precision Oncology |
| Предмети: | |
| Онлайн доступ: | https://jipo.org/doi/pdf/10.36401/JIPO-23-28 |
| Теги: |
Немає тегів, Будьте першим, хто поставить тег для цього запису!
|